S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Abbott Laboratories Outlook is Healthy: Buy the Dip
Closing prices for crude oil, gold and other commodities
Stock market today: World shares are mixed after a tech-led retreat on Wall Street
Prologis Stock Leading U.S. Logistics Boom
OTCMKTS:SSYNF

Arcturis Data (SSYNF) Stock Price, News & Analysis

$0.0002
0.00 (0.00%)
(As of 04/17/2024 ET)
Today's Range
$0.0002
$0.0002
50-Day Range
N/A
52-Week Range
$0.0002
$0.0002
Volume
N/A
Average Volume
136,467 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
SSYNF stock logo

About Arcturis Data Stock (OTCMKTS:SSYNF)

Arcturis Data Limited, a healthcare technology company, develops software products that connects healthcare professionals with patients in the United Kingdom and the United States. Its products include CVm-Health, a web-based application for Covid-19 self-monitoring; DBm-Health, a patient to clinician system that allows health care professionals manage patients with diabetes; GDm-Health, a prescribed digital therapeutic for remote management of diabetes in pregnancy; and BPm-Health that allows pregnant women to self-monitor blood pressure during pregnancy. The company's products also include MagnifEye that allows reading and analysis of diagnostic tests; SEND, an evidence-based digital charting system for vital-signs observations; EDGE, a prescribed digital therapeutic for monitoring chronic obstructive pulmonary disease at home; CleanSpace, a system for monitoring personal exposure to air pollution; Support-HF, a prescribed digital therapeutic for monitoring heart failure at home; Sense, a clinical AI algorithm engine; SYNE-COV, a COVID-19 patient outcome algorithm; and SYNE-OPS, a real-time operational patient management algorithm. It has strategic research alliance with Bayer and Roche; collaboration agreement with Alexion to study the prevalence and outcomes of patients in certain disease areas; research collaboration agreement with Bristol Myers Squibb to apply machine learning for rare blood disease research; research agreement with University of Oxford to conduct a multi-omics drug discovery research project in asthma; strategic research agreement with Milton Keynes University Hospital, Somerset, Hampshire, Royal Wolverhampton, and Royal Devon and Exeter NHS Trusts. The company was formerly known as Sensyne Health Limited and changed its name to Arcturis Data Limited in October 2022. Arcturis Data Limited was incorporated in 2018 and is based in Oxford, the United Kingdom.

SSYNF Stock Price History

SSYNF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive SSYNF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Arcturis Data and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
OTCMKTS:SSYNF
CIK
N/A
Fax
N/A
Employees
158
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

Key Executives

  • Dr. Richard Joseph Pye (Age 47)
    CFO & Executive Director
    Comp: $330.83k
  • Prof. Lionel Tarassenko CBE
    FREng, Director of R&D, Non-Executive Director and Member of Scientific Advisory Board
  • Mr. Alexander Charles Wallace Snow (Age 55)
    CEO & Director
  • Ms. Laura Hillier
    COO, General Counsel & Company Secretary
  • Ms. Julia Wilson
    Director of Investor Relations
  • Dr. Nick Scott-Ram M.A.
    M.B.E., Ph.D., Chief of Analytics, Partnerships & Delivery

SSYNF Stock Analysis - Frequently Asked Questions

How have SSYNF shares performed in 2024?

Arcturis Data's stock was trading at $0.0002 at the start of the year. Since then, SSYNF stock has increased by 0.0% and is now trading at $0.0002.
View the best growth stocks for 2024 here
.

How do I buy shares of Arcturis Data?

Shares of SSYNF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:SSYNF) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners